Generation and Characterization of a Nanobody Against SARS-CoV
SARS-CoV에 대한 나노바디의 생성 및 특성화
Research Article
[키워드] ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
Against
against SARS-CoV
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
antibody
antiviral drug
binding
blocked
caused
characterization
clone
competitive inhibition
coronavirus
demonstrated
domain
E. coli
enzyme
expression
Generation
high affinity
immunized
mononuclear cell
nanobodies
nanobody
neutralization activity
neutralizing antibody
outbreak
Panic
Peripheral blood
Peripheral blood mononuclear cells
positive
pseudovirus
RBD
Receptor-binding domain (RBD)
risk
SARS-CoV
SARS-CoV pseudovirus
SARS-CoV RBD
selected
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus (SARS-CoV)
therapeutic
therapeutic antibodies
Therapeutics
Vaccine
[DOI] 10.1007/s12250-021-00436-1 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1007/s12250-021-00436-1 PMC 바로가기 [Article Type] Research Article